|
| |
Other Emergent BioSolutions Emails
Free Trial
Description: Fuad El-Hibri is Emergent BioSolutions CEO. With a Lead411 subscription, Emergent BioSolutions email addresses ( @emergentbiosolutions.com ) of the executives are viewable. Other information includes Fuad El-Hibri email, phone, biography and extension.
We provide information from your LinkedIn network, see company profile, and soon we will be showing twitter and facebook profiles as well. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to El-Hibri can be found at Executive Directory - El-Hibri.
|
|
BIOGRAPHY:
Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent), a publicly traded biopharmaceutical company focused on developing, manufacturing and commercializing vaccines and therapeutics to prevent and treat life-threatening diseases. The company’s current marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only FDA-licensed vaccine for pre-exposure prophylaxis of anthrax disease. The company is also investing heavily in the development of a broad pipeline of products that address specific global unmet medical needs, including Typhoid, Tuberculosis, Hepatitis B and Chlamydia.
Mr. El-Hibri has extensive experience in the biopharmaceutical industry beginning with Porton Products, Ltd. (Porton), a mid-sized biotechnology company in the United Kingdom. Subsequent to the successful marketing and distribution of Porton’s biodefense vaccines to foreign governments in the early 1990’s, Mr. El-Hibri organized a management buyout of Porton in 1994, forming Speywood Holdings, Ltd. He was appointed to the Board of Directors of Speywood Holdings, Ltd. and acted as an advisor to the senior management team in the operations of the company until 1996.
Starting in the 1990’s, Mr. El-hibri formed and then sold three mobile telecommunications companies, Mobile TeleSystems, serving the greater Moscow region, as well as Digitel and Digicel, serving markets in South and Central America.
Mr. El-Hibri began his career with Citigroup in commercial banking and subsequently in mergers & acquisitions. Following his tenure at Citigroup, Mr. El-Hibri joined Booz Allen & Hamilton as a management consultant in South East Asia, where he led several large client engagements.
Site Reference: http://www.emergentbiosolutions.com/
Fuad El-Hibri Recognized as
... Mar 11, 2010
Emergent BioSolutions to Participate in March 2010 Investor Conferences
Feb 22, 2010
Emergent BioSolutions Announces R. Don Elsey, Chief Financial Officer, to...
Jan 11, 2010
Emergent BioSolutions Reports Financial Results for Full Year 2009 Mar 04, 2010
Emergent BioSolutions to Release Fourth Quarter and Full Year 2009 ... Jan 25, 2010
Emergent BioSolutions Provides Preliminary 2009 Financial Results and ... Jan 11, 2010
HOME | OUR COMPANY | PRODUCT PORTFOLIO | PRESS ROOM | INVESTORS | CAREERS | CONTACT US
SITE MAP | TERMS OF USE | PRIVACY POLICY
document.write(formatDate()); function IMG1_onclick() {}
|
|
|
|
